Glucosamine-linked near-infrared fluorescent probes for imaging of solid tumor xenografts

Molecular Imaging and Biology

Volumn 14, Issue 4, 2012, Pages 443-451

  Korotcov, Alexandru V ^a   Ye, Yunpeng ^a,b   Chen, Yue ^a   Zhang, Fayun ^a   Huang, Sophia ^a   Lin, Stephen ^a   Sridhar, Rajagopalan ^a   Achilefu, Samuel ^b   Wang, Paul C ^a  

^a HOWARD UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cypate; Glucosamine; Near infrared fluorescence; Optical imaging; Prostate cancer; Tumor

Indexed keywords

CYPATE; CYPATE DEXTRO GLUCOSAMINE; DEXTRO GLUCOSAMINE CYPATE DEXTRO GLUCOSAMINE; GLUCOSAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; EX VIVO STUDY; FLUORESCENCE; FLUORESCENCE IMAGING; HALF LIFE TIME; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR PROBE; MOUSE; NEAR INFRARED FLUORESCENCE IMAGING; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; TISSUE DISTRIBUTION; TISSUE SPECIFICITY; TUMOR CELL; TUMOR XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; ENDOCYTOSIS; FLUORESCENT DYES; GLUCOSAMINE; HUMANS; KINETICS; MALE; MICE; MICE, NUDE; MOLECULAR IMAGING; NEOPLASMS; OPTICAL DEVICES; PROSTATIC NEOPLASMS; SPECTROSCOPY, NEAR-INFRARED; TISSUE DISTRIBUTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS; MUS MUSCULUS;

EID: 84865507369     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-011-0520-4     Document Type: Article

References (40)

1. Semmler W, Schwaiger M, Schulz RB (2008) Fundamentals of optical imaging. In: Hofmann FB (ed) Molecular imaging I (handbook of experimental pharmacology), vol. 185/1. Springer, Heidelberg, pp 3-22
2. Ntziachristos V, Bremer C, Weissleder R (2003) Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol 13:195-208 (Pubitemid 36790510)
3. Massoud TF, Gambhir SS (2003) Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 17:545-580 (Pubitemid 36307540)
4. Weissleder R (2001) A clearer vision for in vivo imaging. Nat Biotechnol 19:316-317
5. Ghoroghchian PP, Therien MJ, Hammer DA (2009) In vivo fluorescence imaging: a personal perspective. Wiley Interdiscip Rev Nanomed Nanobiotechnol 1:156-167
6. Shah K, Weissleder R (2005) Molecular optical imaging: applications leading to the development of present day therapeutics. NeuroRX 2:215-225 (Pubitemid 40471433)
7. Hilderbrand SA, Weissleder R (2010) Near-infrared fluorescence: application to in vivo molecular imaging. Curr Opin Chem Biol 14:71-79
8. Eisenblätter M, Höltke C, Persigehl T et al (2010) Optical techniques for the molecular imaging of angiogenesis. Eur J Nucl Med Mol Imaging 37:127-137
9. El-Deiry WS, Sigman CC, Kelloff GJ (2006) Imaging and oncologic drug development. J Clin Oncol 24:3261-3273 (Pubitemid 46628469)
10. Pene F, Courtine E, Cariou A et al (2009) Toward theragnostics. Crit Care Med 37:S50-S58. doi:10.1097/CCM.0b013e3181921349
11. Macheda ML, Rogers S, Best JD (2005) Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol 202:654-662 (Pubitemid 40175840)
12. Shaw RJ (2006) Glucose metabolism and cancer. Curr Opin Cell Biol 18:598-608 (Pubitemid 44692479)
13. Calvo M, Figueroa A, Pulido E et al (2010) Potential role of sugar transporters in cancer and their relationship with anticancer therapy. Int J Endocrinol 2010:14
14. Gambhir SS (2002) Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2:683-693 (Pubitemid 37328919)
15. Gatenby RA, Gillies RJ (2007) Glycolysis in cancer: a potential target for therapy. Int J Biochem Cell Biol 39:1358-1366 (Pubitemid 47031043)
16. Kaarstad K, Bender D, Bentzen L et al (2002) Metabolic fate of 18FFDG in mice bearing either SCCVII squamous cell carcinoma or C3H mammary carcinoma. J Nucl Med 43:940-947 (Pubitemid 34747820)
17. Schwartzenberg-Bar-Yoseph F, Armoni M, Karnieli E (2004) The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res 64:2627-2633 (Pubitemid 38523921)
18. Rubin SJ, Hallahan DE, Ashman CR et al (1991) Two prostate carcinoma cell lines demonstrate abnormalities in tumor suppressor genes. J Surg Oncol 46:31-36
19. Uldry M, Ibberson M, Hosokawa M et al (2002) GLUT2 is a high affinity glucosamine transporter. FEBS Lett 524:199-203 (Pubitemid 34804860)
20. Effert P, Beniers AJ, Tamimi Y et al (2004) Expression of glucose transporter 1 (Glut-1) in cell lines and clinical specimens from human prostate adenocarcinoma. Anticancer Res 24:3057-3064
21. Chandler JD, Williams ED, Slavin JL et al (2003) Expression and localization of GLUT1 and GLUT12 in prostate carcinoma. Cancer 97:2035-2042 (Pubitemid 36397283)
22. Pysz M, Gambhir S, Willmann J (2010) Molecular imaging: current status and emerging strategies. Clin Radiol 65:500-516
23. Cheng Z, Levi J, Xiong Z et al (2006) Near-infrared fluorescent deoxyglucose analogue for tumor optical imaging in cell culture and living mice. Bioconjug Chem 17:662-669 (Pubitemid 43794375)
24. Li C, Greenwood T, Glunde K (2008) Glucosamine-bound near-infrared fluorescent probes with lysosomal specificity for breast tumor imaging. Neoplasia 10:389-398 (Pubitemid 351483579)
25. Ye Y, Bloch S, Kao J et al (2005) Multivalent carbocyanine molecular probes: synthesis and applications. Bioconjug Chem 16:51-61 (Pubitemid 40129677)
26. Yoshioka K, Takahashi H, Homma T et al (1996) A novel fluorescent derivative of glucose applicable to the assessment of glucose uptake activity of Escherichia coli. Biochim Biophys Acta 1289:5-9 (Pubitemid 26075665)
27. O'Neil R, Wu L, Mullani N (2005) Uptake of a fluorescent deoxyglucose analog (2-NBDG) in tumor cells. Mol Imaging Biol 7:388-392 (Pubitemid 44193403)
28. Millon S, Ostrander J, Brown J et al (2011) Uptake of 2-NBDG as a method to monitor therapy response in breast cancer cell lines. Breast Cancer Res Treat 126:55-62
29. Rome L, Hill D (1986) Lysosomal degradation of glycoproteins and glycosaminoglycans. Efflux and recycling of sulphate and Nacetylhexosamines. Biochem J 235:707-713 (Pubitemid 16071979)
30. Jonas AJ, Speller RJ, Conrad PB et al (1989) Transport of N-acetyl-Dglucosamine and N-acetyl-D-galactosamine by rat liver lysosomes. J Biol Chem 264:4953-4956 (Pubitemid 19092906)
31. Virkamäki A, Daniels MC, Hämäläinen S et al (1997) Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance in multiple insulin sensitive tissues. Endocrinology 138:2501-2507 (Pubitemid 27215255)
32. Patti ME, Virkamäki A, Landaker EJ et al (1999) Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle. Diabetes 48:1562-1571 (Pubitemid 29356864)
33. Virkamäki A, Yki-Järvinen H (1999) Allosteric regulation of glycogen synthase and hexokinase by glucosamine-6-phosphate during glucosamine- induced insulin resistance in skeletal muscle and heart. Diabetes 48:1101-1107 (Pubitemid 29226358)
34. Marshall S, Bacote V, Traxinger R (1991) Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 266:4706-4712 (Pubitemid 21909414)
35. Wells L, Vosseller K, Hart G (2001) Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc. Science 291:2376-2378 (Pubitemid 32231793)
36. Yang DJ, Kim C-G, Schechter NR et al (2003) Imaging with 99mTc ECDG targeted at the multifunctional glucose transport system: feasibility study with Rodents1. Radiology 226:465-473 (Pubitemid 36313436)
37. Chen Y, Xiong Q, Yang X et al (2007) Noninvasive scintigraphic detection of tumor with 99mTc-DTPA-deoxyglucose: an experimental study. Cancer Biother Radiopharm 22:403-405 (Pubitemid 47067898)
38. Oh H-J, Lee JS, Song D-K et al (2007) d-Glucosamine inhibits proliferation of human cancer cells through inhibition of p70S6K. Biochem Biophys Res Commun 360:840-845 (Pubitemid 47077397)
39. Park J-Y, Park J-W, Suh S-I et al (2009) d-Glucosamine down-regulates HIF-1[alpha] through inhibition of protein translation in DU145 prostate cancer cells. Biochem Biophys Res Commun 382:96-101
40. Matheson D, Green B, Friedman S (1984) Effect of D-glucosamine on human natural killer activity in vitro. J Biol Response Mod 3:445-453 (Pubitemid 14038686)